Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Seattle Genetics discontinuing lintuzumab in AML

Sep 14 2010

• By Malini Guha

Related Companies

Wyeth

Takeda Pharmaceutical Co. Ltd.

Seagen Inc.

Pfizer Inc.

Genmab A/S

Additional Topics

Canada Clinical Trials Cancer

More from Anticancer

More from Therapeutic Category

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window